Neurofibroma is a benign peripheral nerve sheath tumor and is the most frequent tumor of neural origin. Its presence is one of the clinical criteria for the diagnosis of neurofibromatosis type 1 (NF1; a common hereditary disease occurring in one out of every 3000 births). The diagnosis can sometimes be made at birth, while in others the diagnosis is made later in life after the appearance of additional clinical criteria. Majority of the solitary neurofibromas are sporadic, while a few are associated with NF1 syndrome. Oral hard and soft tissue are affected by the tumor; however, the tongue is the most affected site. Gingival neurofibroma is an uncommon oral manifestation of NF. Here, we report a rare case of gingival neurofibroma in NF1 patient. One of the most feared complications of NF1 is its transformation into neurofibrosarcoma, which bears a very poor prognosis. Treatment of neurofibroma is surgical resection.

Sublingual hematoma secondary to anticoagulation is a rare fatal condition. Hemorrhagic complications of warfarin are well-known. This particular case is unique because the patient was on warfarin for the past 2 years but did not develop the sublingual hematoma. However, a trauma by an attrited sharp cusp triggered the episode of the sublingual hematoma in this patient. Being a medical emergency, patient was promptly hospitalized in cardiac care unit and managed by medical team. The patient was transfused with 2 units of fresh frozen plasma and warfarin was temporarily stopped for 4 days. Alternate day regimen of warfarin was started after 4 days, and international normalized ratio dropped to 3. In dental management, enameloplasty of the mandibular first molar tooth was done to prevent trauma and ulcer development in the floor of the mouth. The hematoma resolved, and no new hematoma formation was observed for a period of 6 months.

Morphological variation of normal oral structures such as double frenum and fusion together in a patient is rare. Sometimes such scenarios may mislead the diagnosis, affecting treatment planning and prognosis. Hence a thorough evaluation of patients with such morphological defects is necessary. This case report describes a case of double frenum and fusion, and the multiple challenges the clinician faces.

Taurodontism is a rare dental morphological anomaly characterised by an unusual increase in the vertical height of the pulpal chamber along with an apical displacement of the pulpal floor. The tooth lack constriction at the cementoenamel junction is mimicking a bull tooth. Taurodontism is usually observed as an isolated tooth aberration. However, it can also be associated with specific syndromes such as Down’s syndrome, amelogenesis imperfecta, Klinefelter syndrome, Tricho-Dento-Osseous syndrome, Mohr syndrome, Prader-Labhart-Willi syndrome, Ellis van Creveld syndrome and Lowe syndrome. Periodontitis is characterised by microbially associated, host‐mediated inflammation that results in loss of periodontal attachment. This case report describes a rare case of non-syndromic generalised taurodontism in a male patient with Stage III Grade C periodontitis. The patient was promptly given periodontal care by root planing and Kirkland flap surgery.

Background: Oral cancer is a health concern in India, accounting for 90% of all head and neck cancers. Recent advances in treatment have improved survival rates, but unbearable pain creates a poor quality of life. Intense pain at the primary site significantly impairs speech, mastication, and swallowing. The use of extensive pain evaluation questionnaire may yield false responses from patients due to severe pain. Aim: The study aims to assess pain management and quality of life using an 8-point questionnaire among patients with squamous cell carcinoma of oral cavity, pharynx, and esophagus undergoing treatment procedures. Materials and Methods: A total of 64 oral cancer patients from two cancer hospitals were interviewed using the self-designed questionnaire to assess their pain level and quality of life. Statistical Analysis: Descriptive analysis was used to describe the frequencies and percentages. Chi-square test was used to determine statistical significance. Results and Conclusion: In 33% of the oral cancer patients, pain medication did not have an analgesic effect; 32.8% of the patients needed stronger pain medication; 36% had severe mood swings; 31.3% had severe sleep disturbance; and 39.1% had severe interference in eating food. On using numeric pain intensity scale, 42.2% had severe pain and 51.5% had moderate pain due to oral, pharyngeal, and esophageal squamous cell carcinoma and its treatment. This simplified questionnaire can be used as a preliminary tool to evaluate oral cancer pain and quality of life.